ABSTRACT
BACKGROUND: The laboratory-based surveillance of antimicrobial resistance (AMR) is a priority component of the multisectoral national action plan to combat AMR in Burkina Faso. This study aimed to assess the QMS of microbiology laboratories involved in the Sentinel laboratory-based antimicrobial resistance surveillance network in Burkina Faso. METHODS: A cross-sectional study was conducted from September 1st to November 30th, 2022. The external quality assessment (EQA) method used was on-site evaluation using a checklist that was developed and validated by a technical committee of experts. Teams of two, including an antimicrobial susceptibility test (AST) specialist and a QMS specialist, were trained on this checklist to conduct the assessment. Satisfactory performance was defined as any on-site evaluation score 80% and above with the aim of developing action plans to address gaps. RESULTS: All 18 laboratories were evaluated. The overall average performance score of the participating laboratories was 40%. The highest overall performance score was 58%, and the lowest overall performance score was 26%. The average overall scores were not significantly different between private and public laboratories (p value = 0.78). The only section of the checklist with the satisfactory performance concerned the "Analytical step of AST", with 76.5% (13/17) of the sentinel laboratories having a score ≥ 80%. CONCLUSION: The performance of the QMS of the sentinel laboratories in Burkina Faso for AMR surveillance was unsatisfactory, and a corrective action plan was proposed to support these laboratories in improving their QMS over the next 3 years.
Subject(s)
Anti-Bacterial Agents , Drug Resistance, Bacterial , Humans , Burkina Faso , Anti-Bacterial Agents/pharmacology , Cross-Sectional Studies , LaboratoriesABSTRACT
Cholera was absent from the island of Hispaniola at least a century before an outbreak that began in Haiti in the fall of 2010. Pulsed-field gel electrophoresis (PFGE) analysis of clinical isolates from the Haiti outbreak and recent global travelers returning to the United States showed indistinguishable PFGE fingerprints. To better explore the genetic ancestry of the Haiti outbreak strain, we acquired 23 whole-genome Vibrio cholerae sequences: 9 isolates obtained in Haiti or the Dominican Republic, 12 PFGE pattern-matched isolates linked to Asia or Africa, and 2 nonmatched outliers from the Western Hemisphere. Phylogenies for whole-genome sequences and core genome single-nucleotide polymorphisms showed that the Haiti outbreak strain is genetically related to strains originating in India and Cameroon. However, because no identical genetic match was found among sequenced contemporary isolates, a definitive genetic origin for the outbreak in Haiti remains speculative.
Subject(s)
Genome, Bacterial , Vibrio cholerae/genetics , Africa/epidemiology , Alleles , Asia/epidemiology , Bacterial Proteins/genetics , Cholera/epidemiology , Cholera Toxin/genetics , Disease Outbreaks , Electrophoresis, Gel, Pulsed-Field , Gene Order , Haiti/epidemiology , Humans , Interspersed Repetitive Sequences/genetics , Phylogeny , Prophages , Sequence Homology, Amino Acid , Vibrio cholerae/classification , Vibrio cholerae/isolation & purificationABSTRACT
To increase understanding of drug-resistant Vibrio cholerae, we studied selected molecular mechanisms of antimicrobial drug resistance in the 2010 Haiti V. cholerae outbreak strain. Most resistance resulted from acquired genes located on an integrating conjugative element showing high homology to an integrating conjugative element identified in a V. cholerae isolate from India.
Subject(s)
Cholera/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Vibrio cholerae O1/drug effects , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Gene Order , Genome, Bacterial , Haiti/epidemiology , Humans , Microbial Sensitivity Tests , Phylogeny , Vibrio cholerae O1/genetics , Vibrio cholerae O1/isolation & purificationABSTRACT
During the last two decade; twelve wild type 1 poliovirus genotypes have been characterized in Africa. Several distinct clusters have been identified within some of them and appeared to be segregated geographically. This distribution could represent newly emerging genotypes and independent sustained circulation of these lineages or cross border transmission between countries of a single genotype followed by a different natural evolution in each country. Concurrent circulation of more than one poliovirus genotype was seen in Nigeria; Togo; Central Africa Republic and South Africa. The present study which has generated a meaningful overview of the endemic circulation of wild type 1 poliovirus in Africa; could be a basis for further evaluation of the impact of mass vaccination campaigns on wild type 1 poliovirus